NCAM1 and Alzheimer disease: On the other hand, a significant increase in the frequency of CLA expression was observed in subjects with severe AD, both in the CD56bright (CD56+CD16−) and CD56dim (CD56+CD16+) NK cell populations (Fig. 1c).